Model‐based meta‐analysis of non‐small cell lung cancer with standard of care PD‐1 inhibitors and chemotherapy for early development decision making
Abstract Single‐arm cohorts/trials are often used in early phase oncology programs to support preliminary clinical activity assessments for investigational products, administered alone or in combination with standard of care (SOC) agents. Benchmarking clinical activity of those combinations against...
Saved in:
Main Authors: | David C. Turner (Author), Russ Wada (Author), Helen Zhou (Author), Xiaowei Wang (Author), Rik deGreef (Author), Chandni Valiathan (Author), Lindsey Zhang (Author), Nancy Zhang (Author), Mita Kuchimanchi (Author), Tai‐Tsang Chen (Author), Marc Ballas (Author), Sandra A. G. Visser (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo
by: Xiaoqiang Liu, et al.
Published: (2019) -
PD-1/PD-L1 pathway and angiogenesis dual recognizable nanoparticles for enhancing chemotherapy of malignant cancer
by: Zhenliang Sun, et al.
Published: (2018) -
Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer
by: Yihang Qi, et al.
Published: (2022) -
Efficacy and Safety of PD-1/PD-L1 Inhibitors in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
by: Zhen-Yu Li, et al.
Published: (2023) -
PK/PD modeling to characterize placebo and treatment effect of omalizumab for chronic spontaneous urticaria
by: Elise Oh, et al.
Published: (2023)